The phylum
Chlamydiae is a unique group of evolutionary well separated, intracellular bacteria that comprises some of the most important bacterial pathogens of humans and animals.
Chlamydia trachomatis is the world's leading cause of preventable blindness [
1] and with over 90 million new cases each year the most frequently sexually transmitted bacterial infection, which can lead to pelvic inflammatory disease, Fallopian tube obstruction, potentially life-threatening ectopic pregnancy, infertility and subfertility [
2].
Chlamydia (a.k.a.
Chlamydophila)
pneumoniae is a causative agent of community acquired pneumonia and might be associated with several chronic diseases such as atherosclerosis [
3,
4].
All recognized chlamydial pathogens form a small group of closely related bacteria constituting the family
Chlamydiaceae within the phylum
Chlamydiae. In addition, seven new families, the
Clavochlamydiaceae,
Criblamydiaceae,
Parachlamydiaceae, Piscichlamydiaceae, Rhabdochlamydiaceae, Simkaniaceae, and
Waddliaceae were recently described within this phylum [
5], revealing a previously underestimated diversity of these elusive microorganisms, which is also represented by their extremely broad host spectrum. More than 60 host species are known, ranging from mammals, marsupials, birds, reptiles, amphibians and fish to insects, crustaceans, molluscs and protozoa [
6]. Moreover, evidence exists that the recognized diversity and host range represent only the tip of the iceberg and that chlamydiae are ubiquitous [
6].
A hallmark of all chlamydiae is their obligate intracellular lifestyle and a developmental cycle consisting of morphologically and physiologically distinct stages. The chlamydial elementary body (EB) is the infectious form that is metabolically inert and can persist in the environment. After infection of a eukaryotic host cell the EB transforms into a reticulate body (RB), which is metabolically active and divides by binary fission within a host-derived vacuole termed inclusion [
7-
9]. Following the replicative phase RBs differentiate to EBs, that are released into the environment either by lysis of the host cell or exocytosis [
10] and a new infection cycle begins.
The crucial step of attachment to and entry into the host cell is mediated by the chlamydial cell envelope, which is one of the most inimitable features of this unique group of microbes. The possible lack of peptidoglycan in chlamydiae is a subject of ongoing discussion [
11], but the difficulties of detecting it clearly support the hypothesis that chlamydiae lack peptidoglycan as main structural and stabilizing element of the cell envelope, which is believed to be substituted by the chlamydial outer membrane complex as a structure-giving component. This assemblage of proteins consists of two cysteine-rich proteins (OmcA and OmcB) and the major outer membrane protein (MOMP, OmpA [
12]). The only other group of well-described chlamydial outer membrane proteins are the polymorphic membrane proteins (Pmps, [
13-
15]) a family of autotransporters. Some Pmps play a role in the attachment to the host cell [
16] and are possibly contributing to tissue specificity of different
C. trachomatis disease groups [
17,
18].
However, despite the importance of outer membrane proteins in the initial steps of host cell invasion, current knowledge about the key players in this process is still scarce. This reflects the general challenges in the analysis of chlamydiae as there are currently no means to genetically manipulate them and hence to characterize protein function by classic genetic methods [
19]. Additionally, hardly any studies attempted to obtain a comprehensive picture of the outer membrane components by a systematic approach [
20,
21]. Among sequenced
Chlamydiaceae genomes, between 31 (
C. trachomatis) and 40 proteins (
C. pneumoniae) are currently annotated as chlamydial outer membrane proteins with most of them belonging to the Pmp family or being classified as lipoproteins. This is a surprisingly low number when compared to other intracellular bacteria with a similar life style and genome size such as
Anaplasma marginale, which has a genome of 1.1 Mb and also replicates in a membrane-enclosed compartment within its host cells. Compared to the
Chlamydiaceae with their 1-1.2 Mb genomes, up to twice as many (62) outer membrane proteins could be identified in the
A. marginale genome [
22]. Furthermore, genomic analysis of the environmental counterpart of the
Chlamydiaceae, the amoeba symbiont
Protochlamydia amoebophila (a member of the
Parachlamydiaceae) [
23], revealed only homologues of the cysteine-rich proteins OmcA and OmcB, but no homologues of other main components of the chlamydial outer membrane complex (MOMP or Pmps). The apparent absence of these dominant proteins and the unexpectedly low number of other annotated outer membrane proteins in
P. amoebophila further illustrate our general lack of knowledge about the outer membrane and suggest that its main components are unique and yet unknown proteins.
To close this gap of knowledge, we have developed an
in silico approach for the identification of yet unknown chlamydial outer membrane proteins (Figure ). An extensive combination of different prediction programs and manual curation steps using conservative criteria were applied to determine a comprehensive and reliable set of chlamydial outer membrane proteins. This approach was tested with the well characterized proteomes of
Escherichia coli and
Bacillus subtilis and subsequently used to predict the outer membrane proteins of five chlamydial species,
Chlamydia trachomatis D/UW3/CX,
Chlamydia muridarum Nigg,
Chlamydia (a.k.a.
Chlamydophila)
pneumoniae AR39,
Chlamydia (a.k.a.
Chlamydophila)
caviae GPIC, and the amoeba symbiont
P. amoebophila UWE25 (Figure ) [
23-
26]. In addition, the taxonomic distribution of the identified outer membrane proteins was analysed to illuminate their conservation throughout the chlamydiae and among representatives of all other bacterial lineages.
Our
in silico analysis predicted 312 outer membrane proteins for the five chlamydial species including more than 100 novel outer membrane proteins of the
Chlamydiaceae despite our conservative approach. A database available online at
http://www.microbial-ecology.net/pcomp was set up and provides access to all predicted outer membrane proteins including details on taxonomic distribution, results of the individual programs used, and links to experimental evidence for their location if available. Taken together, we present a comprehensive and curated set of candidate outer membrane proteins of the
Chlamydiae. As outer membrane proteins are preferred targets for anti-bacterial vaccines, these data can provide guidance for future development of anti-chlamydial immunization strategies.